Trademark applications and grants for Xenoport Inc. Xenoport Inc has 24 trademark applications. The latest application filed is for "TRANSEO"
Patent Application | Date |
---|---|
Oral Dosage Forms Of Methyl Hydrogen Fumarate And Prodrugs Thereof 20200000758 - 16/566696 Virsik; Peter A. ;   et al. | 2020-01-02 |
Pharmaceutical Compositions of Fumaric Acid Esters 20190117776 - 15/980279 Manthati; Suresh Kumar ;   et al. | 2019-04-25 |
TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE 20180273500 - 15/994626 Virsik; Peter A. ;   et al. | 2018-09-27 |
ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE 20180258032 - 15/914621 Gallop; Mark A. ;   et al. | 2018-09-13 |
TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE 20180237405 - 15/957751 Virsik; Peter A. ;   et al. | 2018-08-23 |
NCAGE Code | 6ASQ4 | XENOPORT, INC. |
CAGE Code | 6ASQ4 | XENOPORT, INC. |
SEC | 0001130591 | XENOPORT INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.